2型糖尿病患者如何选择中预混和低预混胰岛素类似物
2016-05-09杨云云王卓
杨云云+王卓
摘 要 糖尿病已成为严重威胁健康的主要慢性疾病之一。中国糖尿病患者数居全球首位,目前2型糖尿病(T2DM)患者呈现出以餐后血糖升高为主,胰岛素敏感性降低和胰岛β细胞功能减退的特点。预混胰岛素类似物根据自身的特点分为中预混和低预混胰岛素,且应用灵活方便,低血糖风险低,更加安全,为2型糖尿病患者带来了新的选择和希望。
关键词 2型糖尿病 中预混胰岛素类似物 低预混胰岛素类似物
中图分类号:R977.15; R458.5 文献标识码:A 文章编号:1006-1533(2016)07-0018-03
How to choose mid-premixed and low-premixed insulin analogue for patients with type 2 diabetes
YANG Yunyun*, WANG Zhuo**
(Department of Pharmacy, Changhai Hospital affiliated to the Second Military Medical University, Shanghai 200433, China)
ABSTRACT Diabetes has become one of the major chronic diseases in the world that is a serious threat to the health of people. The number of Chinese patients with diabetes ranks first in the whole world. Now patients with type 2 diabetes mellitus(T2DM) are primarily characterized as the rise in blood sugar after meals, the decrease of insulin sensitivity and the attenuation of β cell function. Premixed insulin analogs can be divided into mid-premixed or low- premixed insulin based on its own characteristics and can be conveniently applied with lower risk of hypoglycemia and higher safety, which can bring in new choice and hope for patients with type 2 diabetes.
KYE WORDS type 2 diabetes mellitus; mid-premixed insulin analogue; low-premixed insulin analogs
在2型糖尿病患者中,胰岛素作为必要的补充或替代治疗。预混胰岛素类似物同时提供基础和餐食,控制餐后血糖同时兼顾整体血糖的控制,更符合中国2型糖尿病的病理特点[1]。预混胰岛素可分为预混人胰岛素和预混胰岛素类似物,后者可再分为中预混和低预混胰岛素类似物。皮下注射预混胰岛素类似物的吸收、起效较预混人胰岛素更快,可就餐时即刻注射,使用更加方便;峰值水平更高,可应用较小的剂量取得较好的血糖控制。
1 低和中预混胰岛素类似物的定义
预混胰岛素类似物是指将短效胰岛素类似物(赖脯胰岛素或门冬胰岛素)与中效精蛋白锌速效胰岛素类似物按一定比例混合而成的胰岛素制剂,包括低和中预混胰岛素类似物[1]。在这样的背景下,能够同时提供基础和餐时胰岛素的预混胰岛素,被认为是可能提供更加符合亚洲人糖尿病病理生理特点的胰岛素治疗方案。……
